Summary
67 / 100 · Bulios Score
What speaks for it
- It earns 26 USD a year on every 100 USD of invested capital.
- Out of every 100 USD of revenue, 15 USD is left as net profit.
- It holds more cash than debt: $286.2M against $5.89M.
- Analysts expect revenue to grow by 46% this fiscal year.
What to watch
- You pay 76.9 USD for 1 USD of yearly profit, a lot for its sector.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveToday you pay 76.9 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Revenue (USD)
Diluted EPS (USD)
- Analyst estimate
For the next fiscal year analysts expect revenue to grow by 46%.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 15 USD
- Research and development 18 USD
- Sales and administration 54 USD
- Taxes and other -2.1 USD
- Net profit 15 USD
Net profit, industry median (Medical - Healthcare Information Services) 4.7 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 15
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $101.62 is 2.3% below today's price. 94% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
The company reports no revenue by region.
Reportable Segment brings in 100% of revenue.
Segments in detail